Drug Prices
Orbsen announces results from Nephstrom trial
Clinical study is researching patients with diabetes and advanced chronic kidney disease Orbsen…
Drug Prices
Drug Prices
Drug Prices
NICE recommends Alexion’s asfotase alfa across England
Therapy involves patients with paediatric-onset hypophosphatasia – a rare bone disease Alexion Pharma’s…
Drug Prices
Netris Pharma starts hepatocellular carcinoma study
Trial will evaluate efficacy of anti-netrin-1 antibody candidate NP137 in combination with Atezo-bev…
Drug Prices
Gilead’s CAR T-cell therapy recommended for use across the NHS
Treatment involves adult patients with relapsed or refractory diffuse large B-cell lymphoma Gilead…
Drug Prices
Storm reveals STC-15 data for patients with acute myeloid leukaemia
Data shows that STC-15 exhibits efficacy as a single agent and in combination…
Drug Prices
First-in-human implants for Amber Therapeutics’ bioelectrical therapy
Amber-UI presents a significant opportunity to treat urge and mixed urinary incontinence Amber…
Drug Prices
First patients enrolled for Priothera’s mocravimod trial
Treatment is a maintenance therapy for certain patients with acute myeloid leukaemia Priothera…
Drug Prices
NICE recommends Takeda’s Ninlaro triplet regimen
Therapy involves patients living with relapsed or refractory multiple myeloma Takeda has announced…
Drug Prices
NICE recommends PTC Therapeutics’ Translarna reimbursement
The NICE recommendation followed data from clinical trials and real-world evidence PTC Therapeutics…
Drug Prices
Amvuttra recommended by NICE for amyloidosis
Therapy is among the first to receive a positive draft recommendation under streamlined…
